.OS Therapies will certainly note on the NYSE American sell substitution this morning via a $6.4 mil...
.ALX Oncology's period 2 gastric cancer cells action price has diminished. After viewing its CD47 bl...
.One More of Ionis Pharmaceuticals' key midphase readouts has actually disappointed desires, prompti...
.While Biogen's pharma peers are actually hunting for late-stage possessions with little bit of risk...
.Instil Biography has actually been a biotech looking for a pipeline after it scrapped its lead poss...
.Biogen has restored civil liberties to a very early Alzheimer's ailment course to Denali Therapies,...
.Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings ...
.Vertex's attempt to alleviate an unusual genetic disease has actually struck yet another drawback. ...
.Vir Biotechnology's second-quarter incomes report had not been short of big information. The compan...
.Galapagos has stopped enrollment in a test of a BCMA-directed CAR-T cell treatment, pushing the bra...